Navigation Links
Bradmer announces 2008 third quarter operational and financial results
Date:11/10/2008

TSX: BMR

TORONTO, Nov. 10 /PRNewswire-FirstCall/ - Bradmer Pharmaceuticals Inc., a clinical oncology company specializing in the development and commercialization of cancer therapies, today announced its 2008 third quarter operational and financial results.

Operational Highlights

During the three months ended September 30, 2008 and the period subsequent to this date, the Company achieved the following milestones related to its operations and its lead drug, Neuradiab(TM), which is being studied in the Phase III GLASS-ART(TM) Trial:

- Maintained budgetary control and reduced quarterly spending;

- Signed clinical study contracts with nine of the initial 16 sites

under active consideration and activated an initial cohort of five

sites, while advancing a pipeline of additional sites in the US

through the contractual, training and regulatory process;

- Initiated dialog with Health Canada for study expansion into key

Canadian sites with the support of the Canadian Brain Cancer

consortium;

- Enrolled the first group of patients in the GLASS-ART Trial and

successfully dosed patients with Neuradiab at multiple sites;

- Announced new data from the most recent Phase II trial indicating that

the mean time to progression free survival was 77 weeks, which

compares favorably with other published results in newly diagnosed

GBM;

- Evaluated a series of technical steps that may allow a two week

extension of the shelf life of Neuradiab beyond the current six-day

specification; and

- Appointed Dr. Donald Kufe, Professor of Medicine, Harvard Medical

School and Director, Experimental Therapeutics Program, Dana-

Farber/Harvard Cancer Center and Charles James Lilly, CA, a senior

partner with a public accounting firm, to the Board of Directors of

the Company.

"The treat
'/>"/>

SOURCE Bradmer Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Bradmer to present at Rodman & Renshaw Healthcare Conference
2. Bradmer receives FDA approval to proceed with Phase III clinical trial
3. Bradmer announces 2008 first quarter operational and financial results
4. Bradmer announces new additions to management team
5. Bradmer announces 2007 fourth quarter and fiscal year operational and financial results
6. Notice of Bradmer Pharmaceuticals Conference Call
7. Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study
8. Bradmer to present at the 10th Annual BIO CEO & Investor Conference
9. Bradmer announces additions to Scientific Advisory Board
10. Bradmer Medical Isotope Supply For Phase III Trial Secure
11. Bradmer to present at Rodman & Renshaw Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Federally Qualified Health Centers (FQHCs) granted new ... at higher rates than other primary care practices ... according to results of a new 10-state University ... Medical Care . , Using data from a ... 2013, the investigators found that FQHCs community ...
(Date:9/30/2014)... 30, 2014 EverStryke , the permanent ... to SurvivalLife.com along with a free book and class all ... Shane Michaels, prompting an investigative review. , “Joe Marshall ... the survival and preparation niche, and this product is an ... classes and survival products that Joe offers on his website ...
(Date:9/30/2014)... Minn. (PRWEB) September 30, 2014 For ... to the apple orchard, pumpkin patch or annual festival. ... for fast-spreading viruses – like the respiratory infection Enterovirus ... in most children, a small percentage – especially children ... symptoms. Increased concern about the Enterovirus is prompting hospitals ...
(Date:9/30/2014)... TOWNSHIP, Mich. (PRWEB) September 30, 2014 ... chronic knee pain program of care that ... , His clinic—Johnson Chiropractic Neurology & Nutrition—applies ... on the knee. It also addresses sources of inflammation, ... well as the “neurokinetic chain” from the brain to ...
(Date:9/30/2014)... has made progress in reducing the stigma associated with ... post-traumatic stress disorder, but more improvement is still needed, ... efforts of both the Defense Department and the Veterans ... members still do not seek needed care for ... effort to promote treatment as a way to reduce ...
Breaking Medicine News(10 mins):Health News:Medicaid and Uninsured patients obtain new patient appointments most easily at FQHCs 2Health News:EverStryke: Review Exposes Joe Marshall’s Permanent Match Survival Product 2Health News:As Hospitals Combat Enterovirus Outbreaks, Patients and Families Turn to “Virtual Visits” with CaringBridge 2Health News:Newly Developed Program Eases Chronic Knee Pain without Surgery and in as Little as Two Days 2Health News:Newly Developed Program Eases Chronic Knee Pain without Surgery and in as Little as Two Days 3Health News:US military making progress reducing stigma tied to seeking help for mental illness 2Health News:US military making progress reducing stigma tied to seeking help for mental illness 3
... Cornwall Primary Care Trust (PCT) has revealed that patients who ... as it lacks the funds for non-urgent cases//. The Royal ... not permit himself to be forced to follow the new ... for patients. ,He feels that a waiting list ...
... stroke, three leading killers in the U.S., all dropped in ... ,Also, Americans' life expectancy increased again in 2003, up ... in 1990. ,Life expectancy in the U.S. has ... including advances in medicine and sanitation, and declines in unhealthy ...
... which are proved to be better than older drugs ... benefit of these drugs could be realized reports//, Medicine ... Frontiers) have accused the pharmaceutical companies that they are ... providing AIDS treatment to over 57,000 people in 29 ...
... caused the death of a 5 year old boy in Thailand ... is not found to be in direct contact with chickens, but ... the neighboring poultry. ,The latest good news to ease ... the patent for Tamiflu drug has given permission to manufacturers to ...
... overweight people—they cannot reduce weight by exercise due to ... often prescribe exercise as part of a regime to ... psychologist Rona Levy at the University of Washington have ... hampered by a variety of gastrointestinal problems that frequently ...
... be a stimulation to be relieved as survivors have ... ,This arises due to its treatment and or shared ... population. ,According to the study the most likely ... cancer, renal cancer, thyroid cancer, soft tissue sarcoma, endometrial ...
Cached Medicine News:Health News:US life expectancy climbs to a new high 2
(Date:9/30/2014)... Resources Group finds that the Asia Pacific ... , India , Japan ... Dental implant procedure volumes will grow as physicians are increasingly trained ... key findings from Decision Resources Group,s coverage of the ... Dental implant penetration: Penetration of dental implants among the ...
(Date:9/30/2014)... 30, 2014 A study using a relatively ... new look at the composition of carotid artery disease ... and treat the disease, a leading cause of stroke. ... Lexington between September 2010 and May 2012, was featured ... of the American College of Cardiology (JACC) Cardiovascular Interventions. ...
(Date:9/30/2014)... Calif. , Sept. 30, 2014 ... of the American Association of Tissue Banks (AATB), ... , Chief Executive Officer. Accreditation follows ... by a specially trained AATB inspector.  It establishes ... performance within the facility meets or exceeds the ...
Breaking Medicine Technology:Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 2Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 3New Imaging Tool May Allow Tailoring of Stroke Prevention to Each Patient 2Biostructures, LLC Earns AATB Accreditation 2
... Lilly and Company (NYSE: LLY ) today ... Radiopharmaceuticals, Inc., a privately held company developing novel molecular ... chronic human diseases. The transaction, first announced on November ... and clearance under the Hart-Scott-Rodino Antitrust Improvements Act. All ...
... year, the Food and Drug Administration (FDA) approves many ... and help consumers save money. To read ... to http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm236544.htm . Sign up for ... https://service.govdelivery.com/service/subscribe.html?code=USFDA_9 . View the ...
Cached Medicine Technology:Lilly Announces Completion of Avid Acquisition and FDA Priority Review for florbetapir 2
... first 192 channel simultaneous sampling EEG with ... routine EEG exam rooms as well as ... Optional analysis software for automatic spike ... sleep analysis. Quality Data Acquisition ,The ...
Optoelectronic stimulator, "ganzfeld" stimulations for flash VEP, flash ERG and sensory EOG. Pattern stimulations for ERG and VEP, multifocal stimulations for ERG and VEP, complies with international...
... The VISULAS 690s is the ... the instrument of choice for ... clinical trials, Carl Zeiss has ... in laser manufacturing to create ...
The SL 115 Classic Slit Lamp offers you high optical performance and convenient operation. It is not only the ideal instrument for all routine examinations and contact lens fitting, but is also excel...
Medicine Products: